Who is the patent right of clone technology

Introduction: today, sheep, cattle, pigs, mice and monkeys have been cloned one after another With the rapid development of animal cloning technology, the market of animal cloning shows a very attractive prospect Among them, an attractive and cruel fact is that whoever can obtain the patent right of the core technology of cloning will become the "leader" of the cloning animal industry Advanced cell technologies (a CT) charges $20000 per cow Last year, the company earned as much as $1 million from licensing fees to other companies Weste, the company's president, said the market potential for embryonic stem cells for therapeutic purposes could reach $10 billion Therefore, the U.S "g Eron", "advanced cell technology" (a CT) and "infinite gene" (I nfigen) three cloned animal companies have almost reached a white hot battle for the patent rights of core technology They all claim to own this core patented technology P8c, a California based Keelung company, entered this field only after acquiring Roslin B IO Med company, a subsidiary of Dolly sheep company cloned in 1999 They study embryonic stem cells for disease treatment, with an annual income of $3.6 million The Massachusetts based advanced cell technology company is famous for its claim to clone human embryonic stem cells The company mainly clones cows and other animals with an annual income of $2 million Infinite gene, a Wisconsin based company that specializes in cloning cattle and pigs, develops animal cloning technology to produce medical products for humans P8c in January this year, the U.S patent office agreed to investigate a patent claim of Keelung company, which requires advanced cell technology company to withdraw an important cloned animal patent Keelung believes that this technology was invented and first used by its original Roslin B IO Med company By March 11, the dispute had entered a more complex stage The U.S Patent Office said it will investigate whether infinite gene's application for a patent for animal cloning overlaps with Keelung's disputed patent rights At the same time, infinite gene company is also fighting a lawsuit with advanced cell technology company about the patent right of the same core technology P8c can see that the above three companies are willing to spend "small money" to fight such lawsuits in order to be "famous" At present, the animal cloning industry has not reached the level of profitability Every successful animal cloning will be accompanied by hundreds of failures Therefore, they should continue to absorb venture capital to maintain their company's operation Winning a patent case means that venture capital is rolling in P8c advanced cell technology announced last November that it had cloned human embryos However, experts from rival companies immediately "corrected": they did not succeed in producing only cells that had died before they became viable stem cells The reason advanced cell technology companies claim this is to attract the attention of venture capitalists Currently, the company has raised $12 million in venture capital and plans to raise another $10 million to $15 million P8c relevant people predict that two lawsuits of the three companies may take one or two years to find out who owns the disputed technology patent finally The U.S patent office must consider who invented the cloning method first and who put it into practice more efficiently Among the three companies, Keelung is considered to be in a favorable position Okoma, the company's president, thinks their company will win He said, "we have dolly sheep We are not afraid." However, according to the patent lawyer, poplavsky, the final outcome may be that each of the three companies has obtained a patent right, which is only different in the use of cell types and preparation methods In fact, the scope of a patent that is finally approved is often not as large as it was originally applied for However, no matter what the result is, one or three companies have monopolized or divided the core technology patents of cloned animals It is an important patent strategy of American companies to compete for patent rights while developing new technologies It is this strategy that makes American large companies succeed in complex business wars If p8c monopolizes a technology, it will monopolize an industry This is true of IBM and Microsoft In the future, all successful new technology companies will consciously or unconsciously follow this path P8c (author:) to feed Weibo to: